NKTR News

NKTR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit

Pomerantz LLP Announces Class Action Lawsuit Filing Against Nektar Therapeutics – NKTR

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

NKTR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026

NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Failing Clinical Enrollment Standards: Levi & Korsinsky

NKTR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Announces Commencement of Class Action Lawsuit Against Nektar Therapeutics – NKTR

ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR